Innovation and Access to Medicine: Implementation of Patent Linkage and Data Exclusivity in Taiwan
On 20 August 2019 the newly established patent linkage has taken effect in Taiwan. Apart from that the patent linkage enhancing the enforcement of pharmaceutical patents, the Pharmaceutical Affairs Act provides data exclusivity protection on the new chemical entity (NCE) and new indication drugs. This article is of the opinion that intellectual property protection for pharmaceuticals is essential for access to medicines, acceleration of launching innovation drug and establishment of domestic pharmaceutical industry in Taiwan. Domestic companies which are capable of launching new dosage forms of existing drugs need more incentives provided by patent linkage and data exclusivity to undertake R&D.